Brain imaging of schizophrenia - The dopamine hypothesis

Schizophrenia Research

Volumn 28, Issue 2-3, 1997, Pages 157-162

  Farde, Lars ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

D2 dopamine receptors; Dopamine; Neurologic drugs; Positron Emission Tomography (PET); Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; POSTSYNAPTIC RECEPTOR;

BRAIN TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; HUMAN; HYPOTHESIS; LIMBIC SYSTEM; NEOCORTEX; POSITRON EMISSION TOMOGRAPHY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AMPHETAMINES; ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN CHEMISTRY; HUMANS; NEURAL PATHWAYS; RECEPTORS, DOPAMINE; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031578942     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(97)00121-7     Document Type: Conference Paper

References (46)

1. Andreasen, N., Olson, S., 1982. Negative versus positive schizophrenia: definition and validation. Arch. Gen. Psychiat. 39, 789-794.
2. Baron, J.C., Martinot, J.L., Cambon, H., Boulenger, J.P., Poirier, M.F., Caillard, V., Blin, J., Huret, J.D., Loc'h, C., Maziere, B., 1989. Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology 99, 463-472.
3. Bracha, H., 1987. Asymmetric rotational (circling) behavior, a dopamine-related asymmetry: preliminary findings in unmedicated and never-medicated schizophrenic patients. Biol. Psychiatry 22, 995-1003.
4. Carlsson, A., 1978. Antipsychotic drugs, neurotransmitters, and schizophrenia. Am. J. Psychiatry 135, 164-173.
5. Carlsson, A., Lindqvist, M., 1963. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. 20, 140-144.
6. Conell, P., 1958. Amphetamine Psychosis. Chapman and Hall, Chapman and Hall.
7. Creese, I., Burt, D.R., Snyder, S.H., 1976. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192, 481-483.
8. Crow, T.J., 1980. Molecular pathology of schizophrenia: more than one disease process? Br. Med. J. 280, 66-68.
9. Dewey, S.L., Logan, J., Wolf, A.P., Brodie, J.D., Angrist, B., Fowler, J.S., Volkow, N.D., 1991. Amphetamine induced decreases in (F-18)-N-Methylspiroperidol binding in the baboon brain using positron emission tomography (PET). Synapse 7, 324-327.
10. Early, T., Reiman, E., Raichle, M., Spitznagel, E., 1987. Left globus pallidus abnormality in never-medicated patients with schizophrenia. Proc. Natl Acad. Sci. USA 84, 561-563.
11. 2 dopamine receptor binding in the living human brain by PET. Science 231, 258-261.
12. 2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch. Gen. Psychiatry 45, 71-76.
13. 2 dopamine receptors in neuroleptic-naïve schizophrenic patients. Arch. Gen. Psychiatry 47, 213-219.
14. Farde, L., Nordström, A.-L., Wiesel, F.-A., Pauli, S., Halldin, C., Sedvall, G., 1992. PET-analysis of central D1-and D2-dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine - relation to extrapyramidal side effects. Arch. Gen. Psychiatry 49, 538-544.
15. 11C]raclopride in man. Synapse 20, 200-208.
16. 2-dopamine receptors and personality traits. Nature 385, 590
17. 2 -dopamine receptors in healthy subjects and antipsychotic drug treated patients. Psychopharmacology, 133, 96-107.
18. Ginovart, N., Farde, L., Swahn, C., Halldin, C., 1997. Effect of reserpine on endogenous dopamine levels in the monkey brain. Synapse 25, 321-325.
19. Goldman-Rakic, P.S., Lidow, M.S., Smiley, J.F., Williams, M.S., 1992. The anatomy of dopamine in monkey and human prefrontal cortex. J. Neural Transm. Suppl 36, 163-177.
20. Goode, D., Manning, A., 1988. Specific imbalance of right and left sided motor neuron excitability in never-medicated patients with schizophrenia. J. neurol. Neurosurg. Psychiatry 51, 626-629.
21. 2 receptors. Preparation, metabolite studies and in vivo distribution in the monkey brain using PET. 1995. J. Nucl. Med. 36, 1275-1281.
22. 2-dopamine receptor characteristics in neuroleptic-naïve schizophrenic patients studied with positron emission tomography. Arch. Gen. Psychiatry 51, 116-123.
23. Hietala, J., Syvälahti, E., Vuorio, K., Räkköläinen, V., Bergman, J., Haaparanta, M., Solin, O., Kuoppamäki, M., Kirvelä, O., Ruotsalianen, U., Salokangas, R., 1995. Presynaptic dopamine function in striatum of neurolepticnaïve schizophrenic patients. Lancet 346, 1130-1131.
24. Jackson, J., 1931. Selected Writings of J. H. Jackson. Hodder and Stoughton, London.
25. 125I] epidepride. Brain Research 609, 237-243.
26. 3H-Spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J. Neural Transm. 75, 1-10.
27. Laruelle, M., Abi-Dargham, A., van Dyck, C, Gil, R., D'Souza, C., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S., Baldwin, R., Seibyl, J., Krystal, J., Charney, D., Innis, R. (1996) SPECT imaging of amphetamine-induced dopamine activity in drug free schizophrenic subjects. Proc. Natl. Acad. Sci. USA 93, 9235-9240.
28. Mackay, A., Iversen, L., Rossor, M., Spokes, E., Bird, E., Arregui, A., Creese, I., Snyder, S., 1982. Increased brain dopamine and dopamine receptors in schizophrenia. Arch. Gen. Psychiatry 39, 991-997.
29. Meltzer, H., Sommers, A., Luchins, D., 1986. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia. J. Clin. Psychopharmacol. 6, 329-338.
30. 11C]NMSP. Psychiatry Research 61, 67-83.
31. Owen, F., Cross, A., Waddington, J., 1980).Dopamine mediated behaviour and 3H-spiperoine binding to striatal membranes in rats after nine months haloperidol administration. Life Sci. 26, 55-59.
32. 2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 1231IBZM single photon emission computerised tomography study. Br. J. Psychiatry 164, 16-26.
33. Randrup, A., Munkvad, I., 1967. Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia (Berl.) 11, 300-310.
34. Reynolds, G.P., 1983. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305. 527-529.
35. Reynolds, G., Mason, S., 1994. Are striatal dopamine D4 rewceptors increased in schizophrenia? J. Neurochem. 63, 1576-1577.
36. Sedvall, G., Farde, L., 1995. Chemical brain anatomy in schizophrenia. The Lancet 346, 743-749.
37. Seeman, P., Lee, T., Chau-Wong, M, Wong, K., 1976. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261, 717-719.
38. Seeman, P., Ulpian, C, Bergeron, C, Riederer, P., Jellinger, K., Gabriel, E., Reynolds, G.P., Tourtellotte, W.W., 1984. Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science 225, 728-731.
39. 3H]raclopride: implications for positron emission tomography of the human brain. 1989. Synapse 3, 96-97.
40. Seeman, P., Guan, H.C., Vantol, H.H.M., 1993. Dopamine D4 receptors elevated in schizophrenia. Nature 365, 441-445.
41. 2 receptor occupancy in schizophrenic patients. Biol. Psychiatry 23, 653-663.
42. 11C-N-methylspiperone. Psychiatry Res. 49 (3), 219-237.
43. Van Rossum, J., 1967. The significance of dopamine receptor blockade for the action of neuroleptic drugs. In: Brill, H., Cole, J., Deniker, P., Hippius, H., Bradley, P. (Eds) Proceedings of the 5th CINP, Washington DC, pp. 321-329.
44. Weinberger, D.R., Berman, K.F., Daniel, D.G., 1992. Mesoprefrontal cortical dopaminergic activity and prefrontal hypofunction in schizophrenia. Clin. Neuropharmacol. 15, 568A-569A.
45. Wong, D., Gjedde, A., Wagner Jr., H., 1986a. Quantification of neuroreceptors in the living human brain I. Irreversible binding of ligands. J. Cereb. Blood Flow Metab. 6, 137-146.
46. 2-dopamine receptors in drug-naïve schizophrenics. Science 234, 1558-1563.